MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
The review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment b...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2015-01-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/212 |
_version_ | 1826561396872052736 |
---|---|
author | V. N. Soboleva E. O. Taratukhin |
author_facet | V. N. Soboleva E. O. Taratukhin |
author_sort | V. N. Soboleva |
collection | DOAJ |
description | The review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment by the growth of receptor interaction selectiveness. |
first_indexed | 2024-04-09T20:50:24Z |
format | Article |
id | doaj.art-dd591152d59a40939af020e6f076b4f4 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2025-03-14T09:31:31Z |
publishDate | 2015-01-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-dd591152d59a40939af020e6f076b4f42025-03-02T11:42:35Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202015-01-010110410610.15829/1560-4071-2015-1-104-106212MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENTV. N. Soboleva0E. O. Taratukhin1SBEI HPE RNRMU n. a.N.I.Pirogov, Moscow, RussiaSBEI HPE RNRMU n. a.N.I.Pirogov, Moscow, RussiaThe review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment by the growth of receptor interaction selectiveness.https://russjcardiol.elpub.ru/jour/article/view/212aldosteronemineralocorticoidscardiovascular mortalitymyocardial infarctioneplerenonespironolactone |
spellingShingle | V. N. Soboleva E. O. Taratukhin MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT Российский кардиологический журнал aldosterone mineralocorticoids cardiovascular mortality myocardial infarction eplerenone spironolactone |
title | MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT |
title_full | MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT |
title_fullStr | MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT |
title_full_unstemmed | MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT |
title_short | MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT |
title_sort | mineralocorticoid antagonism selectiveness gives more opportunities for heart failure management |
topic | aldosterone mineralocorticoids cardiovascular mortality myocardial infarction eplerenone spironolactone |
url | https://russjcardiol.elpub.ru/jour/article/view/212 |
work_keys_str_mv | AT vnsoboleva mineralocorticoidantagonismselectivenessgivesmoreopportunitiesforheartfailuremanagement AT eotaratukhin mineralocorticoidantagonismselectivenessgivesmoreopportunitiesforheartfailuremanagement |